Soluble urokinase plasminogen activator receptor and cardiotoxicity in doxorubicin-treated breast cancer patients: a prospective exploratory study

Abstract Background Soluble urokinase plasminogen activator receptor is an inflammatory biomarker that may prognosticate cardiovascular outcomes. We sought to determine the associations between soluble urokinase plasminogen activator receptor and established markers of cardiotoxicity in breast cance...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Jian Chu, Lillian Tung, Issam Atallah, Changli Wei, Melody Cobleigh, Ruta Rao, Steven B. Feinstein, Lydia Usha, Kathrin Banach, Jochen Reiser, Tochukwu M. Okwuosa
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	BMC 2024-01-01
Schriftenreihe:	Cardio-Oncology
Schlagworte:	Soluble urokinase Plasminogen Activator Receptor (suPAR) Biomarker Global longitudinal strain (GLS) Echocardiography B-type natriuretic peptide (BNP) Troponin
Online-Zugang:	https://doi.org/10.1186/s40959-023-00191-0
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!